BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst.
The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches.
The San Jose, Calif.–based company offers a turnkey digital health platform for medtech and biopharma. BrightInsight developed its platform under a quality management system to support its customers’ global security, privacy, and regulatory requirements.
“This financing led by General Catalyst not only validates the market need for a global digital health platform for biopharma and medtech, but it also reinforces the tremendous progress we have made in the past year,” said Dr. Kal Patel, BrightInsight’s CEO and fo-founder.
“Our Series C round will enable BrightInsight to continue our hypergrowth and to support the development and launch of game-changing digi…